{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:03:04Z","timestamp":1781020984076,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcin.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T18:30:06Z","timestamp":1779733806000},"page":"1307-1309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral Anticoagulation Alone or With Antiplatelet Therapy Among Patients With Coronary (and Other Vascular) Disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.jcin.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jcin.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"21","key":"10.1016\/j.jcin.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.282.21.2058","article-title":"Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis","volume":"282","author":"Anand","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2026.04.005_bib4","doi-asserted-by":"crossref","unstructured":"Fauchier L, Guglieri M, Bisson A, Lenormand T, Lip GYH. Antiplatelet therapy in patients with stable coronary artery disease who require long-term oral anticoagulation. Eur J Intern Med. Published online December 29, 2025. https:\/\/doi.org\/10.1016\/j.ejim.2025.106684.","DOI":"10.1016\/j.ejim.2025.106684"},{"issue":"10","key":"10.1016\/j.jcin.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jcin.2026.03.020","article-title":"Oral anticoagulation with or without antiplatelet therapy in chronic coronary syndrome: a meta-analysis of randomized trial","volume":"19","author":"Galli","year":"2026","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jcin.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12916-024-03792-3","article-title":"Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries","volume":"22","author":"Mei","year":"2024","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jcin.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12916-024-03338-7","article-title":"The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study","volume":"22","author":"Tsai","year":"2024","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.jcin.2026.04.005_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.jcin.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaneurol.2025.1337","article-title":"Residual risk of recurrent stroke despite anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"82","author":"McCabe","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jcin.2026.04.005_bib10","doi-asserted-by":"crossref","unstructured":"Romiti GF, Corica B, Bucci T, et al. The \u201cAtrial Fibrillation Better Care\u201d (ABC) pathway for integrated care of atrial fibrillation: a systematic review and meta-analysis. Thromb Haemost. Published online January 30, 2026. https:\/\/doi.org\/10.1055\/a-2787-0186.","DOI":"10.1055\/a-2787-0186"},{"issue":"6","key":"10.1016\/j.jcin.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11606-024-09037-6","article-title":"Efficacy of the ABC pathway for integrated care across phenotypes of patients with atrial fibrillation: a latent-class analysis report from the mAFA-II clinical trial","volume":"40","author":"Corica","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.jcin.2026.04.005_bib12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician\u2019s perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jcin.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-Asian cohorts","volume":"125","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"issue":"39","key":"10.1016\/j.jcin.2026.04.005_bib14","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1093\/eurheartj\/ehae558","article-title":"Variation in secondary prevention of coronary heart disease: the INTERASPIRE study","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jcin.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.jcin.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jcin.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian Paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb Haemost"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879826011490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879826011490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:42:44Z","timestamp":1781019764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879826011490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1936879826011490"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2026.04.005","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Anticoagulation Alone or With Antiplatelet Therapy Among Patients With Coronary (and Other Vascular) Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2026.03.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}